<DOC>
	<DOCNO>NCT00578773</DOCNO>
	<brief_summary>The purpose study determine otic formulation safe effective treat peri-operative tube otorrhea .</brief_summary>
	<brief_title>A Phase II Study Otic Formulation Treating Peri-Operative Tube Otorrhea</brief_title>
	<detailed_description />
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>6 month 12 year old Diagnosed recurrent acute otitis medium chronic otitis medium effusion Must first set ear tube . Patient may previous otologicrelated surgery . Ear tube may silver oxide , silver salt , ttype tube longshafted tube Patient may exist perforation eardrum . Patient must require another surgical procedure myringotomy tube insertion . Patient may menarchal female Diabetic patient eligible Patient may disease condition would negatively affect conduct study Patient may require systemic antimicrobial therapy study . Patient must meet certain medication washout eligible Analgesic use ( acetaminophen ) allow Patient may predispose neurosensory hearing loss Other protocoldefined inclusion criterion may apply Age Other protocoldefined exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>ear tube</keyword>
	<keyword>ear infection</keyword>
	<keyword>ear drop</keyword>
	<keyword>ear tube surgery</keyword>
	<keyword>acute otitis medium</keyword>
</DOC>